🇺🇸 PF-07220060 + PF-07104091 combination dose escalation in United States

PF-07220060 + PF-07104091 combination dose escalation (pf-07220060-pf-07104091-combination-dose-escalation) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PF-07220060 + PF-07104091 combination dose escalation in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is PF-07220060 + PF-07104091 combination dose escalation approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PF-07220060 + PF-07104091 combination dose escalation in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.